Mungmunpuntipantip, R. & Wiwanitkit, V. (2022). Letter to the Editor in Response to the "Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm". Iranian Journal of Immunology, 19(4), 446–447. https://doi.org/10.22034/iji.2022.96908.2466
MLA
Mungmunpuntipantip, R., & Wiwanitkit, V. "Letter to the Editor in Response to the "Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm"", Iranian Journal of Immunology, 19, 4, 2022, 446–447. doi: 10.22034/iji.2022.96908.2466
HARVARD
Mungmunpuntipantip, R., & Wiwanitkit, V. (2022). 'Letter to the Editor in Response to the "Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm"', Iranian Journal of Immunology, 19(4), pp. 446–447. doi: 10.22034/iji.2022.96908.2466
CHICAGO
Mungmunpuntipantip, R. & Wiwanitkit, V., "Letter to the Editor in Response to the "Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm"." Iranian Journal of Immunology, 19 4 (2022): 446–447, doi: 10.22034/iji.2022.96908.2466
VANCOUVER
Mungmunpuntipantip R., Wiwanitkit V. Letter to the Editor in Response to the "Comparison of the Antibody Responses Following Vaccination with AstraZeneca and Sinopharm". Iran.J.Immunol. 2022;19(4):446–447. doi: 10.22034/iji.2022.96908.2466
